Efficacy of MicrOnized Purified Flavonoid Fraction in PoST-Hemorrhoidectomy Period (MOST Trial): Open-Label Randomized Controlled Trial

Yuliya Medkova,Inna Tulina,Valeriya Yudina,Ruslan Abdullaev,Scherbakova Vlada,Ivan Novikov,Andrey Nikonov,Petr Tsarkov
DOI: https://doi.org/10.1097/dcr.0000000000003211
2024-02-21
Diseases of the Colon & Rectum
Abstract:BACKGROUND: Frequent early postoperative complication of hemorrhoidectomy is thrombosis and edema of mucocutaneous “bridges.” OBJECTIVE: We investigated the efficacy of micronized purified flavonoid fraction in preventing complications following elective hemorrhoidectomy. DESIGN: Prospective unicentral open-label randomized controlled trial. SETTINGS: 2021-2022 Clinic of Colorectal and Minimally Invasive Surgery Sechenov University (Moscow, Russia). PATIENTS: Patients after hemorrhoidectomy, which was done for grade III-IV hemorrhoids INTERVENTIONS: After hemorrhoidectomy, patients were randomly allocated either to standard treatment (peroral non-steroid anti-inflammatory drugs and local anesthetics, topical steroids, psyllium, warm sitz baths, nifedipine gel) – control group, or to standard treatment with micronized purified flavonoid fraction (study group) and followed for 60 days. MAIN OUTCOME MEASURES: Thrombosis or edema of mucocutaneous bridges and pain intensity on a visual analogue scale оn 1st-7th, 14th , 21st and 30th postoperative day; quality of life and patient-assessed treatment effect оn 1st, 3rd, 7th, 21st and 30th postoperative day; perianal skin tags оn 60th postoperative day. RESULTS: The data from 50 patients were analyzed (25 in each group). Visual analogue scale demonstrated nо differences between groups in each follow-up point. Compared to control group, the patients in study group had significantly higher patient-assessed treatment effect оn 1st, 3rd, 7th, 21st and 30th post operative days, significantly lower rate of thrombosis or edema of mucocutaneous bridges оn 1st-7th, and 14th days. Patients in the study group had significantly lower rates of perianal skin tags. LIMITATIONS: Unicenter open-label design. CONCLUSIONS: Micronized purified flavonoid fraction in the post-hemorrhoidectomy period is an effective adjunct to standard treatment that helps reduce the rate of thrombosis and edema of mucocutaneous bridges, improves patient-assessed treatment effect, and prevents postoperative perianal skin tags formation. Micronized purified flavonoid fraction in the post-hemorrhoidectomy period is not associated with additional pain relief in comparison with non-micronized purified flavonoid fraction standard treatment. See Video Abstract .
gastroenterology & hepatology,surgery
What problem does this paper attempt to address?